MedPath

Development of new fluorescence cytology using 5-ALA in breast cancer

Phase 1
Recruiting
Conditions
breast cancer
Registration Number
JPRN-UMIN000029266
Lead Sponsor
Kyoto Prefectural University of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who is determined inappropriate to participate in the study by the attending physician Patients with inoperable advanced recurrent breast cancer

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity and specificity of primary tumor and lymph node metastasis using fluorescence diagnosticssa
Secondary Outcome Measures
NameTimeMethod
The comparison to the difference in fluorescence between normal and cancer cells, The comparison to the difference in fluorescence between normal and metastatic lymph nodes, Analysis by breast cancer subtype
© Copyright 2025. All Rights Reserved by MedPath